Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 05/05/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

A phase II, multicenter, open-label trial to evaluate the safety and efficacy of ISU303 (Agalsidase beta) in patients with Fabry disease.

Condition: Fabry Disease (FD)
Journal: Medicine
Treatment Used: Agalsidase Beta
Number of Patients: 10
Published: September 20, 2022

Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).

Condition: Fabry Disease (FD)
Journal: European heart journal. Cardiovascular pharmacotherapy
Treatment Used: Migalastat
Number of Patients: 54
Published: May 05, 2022

Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report.

Condition: Membranous Nephropathy (MN) in Fabry Disease
Journal: Medicine
Treatment Used: Agalsidase-β and Carbamazepine
Number of Patients: 1
Published: April 01, 2022

Chaperone Therapy in Fabry Disease.

Condition: Fabry Disease
Journal: International journal of molecular sciences
Treatment Used: Chaperone Therapy
Number of Patients: 0
Published: February 15, 2022

Stroke and stroke-like episodes in inborn errors of metabolism: Pathophysiological and clinical implications.

Journal: Molecular genetics and metabolism
Published: January 08, 2022

Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis.

Condition: Fabry Disease
Journal: International journal of medical sciences
Treatment Used: Enzyme Replacement Therapy (ERT)
Number of Patients: 552
Published: January 03, 2022

Tissue Characterization in Cardiology: Moving Beyond Function.

Journal: Advances in experimental medicine and biology
Published: January 01, 2022

Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation.

Journal: Frontiers in immunology
Published: December 17, 2021

Nationwide screening for Fabry disease in unselected stroke patients.

Journal: PloS one
Published: December 14, 2021

Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson-Fabry disease.

Journal: Cell death & disease
Published: December 13, 2021

Variable expression of eighteen common housekeeping genes in human non-cancerous kidney biopsies.

Journal: PloS one
Published: December 09, 2021

The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process.

Condition: Canadian Patients with Fabry Disease
Journal: Drugs in R&D
Treatment Used: Agalsidase Alfa Enzyme Replacement Therapy
Number of Patients: 167
Published: September 20, 2021
Showing 1-12 of 44

Last Updated: 05/05/2023